Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2021
Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohortOlivia Chin, Eugene Yu, Brian O'Sullivan, et al.The Journal of Urology|February 24, 2018
Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell TumorRicardo Leão, Ton van Agthoven, Arnaldo Figueiredo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomasShao Hui Huang, Wei Xu, John Waldron, et al.JCO Global Oncology|February 29, 2020
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large CohortsDominick Bossé, Wanling Xie, Xun Lin, et al.International Journal of Cancer|January 31, 2019
Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck regionJianjun Ren, Wen Yang, Jie Su, et al.Cell Death and Differentiation|February 26, 2024
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neckEnrique Sanz-Garcia, Jinfeng Zou, Lisa Avery, et al.Head & Neck|June 6, 2017
Morphologic and topographic radiologic features of human papillomavirus-related and -unrelated oropharyngeal carcinomaMichael W Chan, Eugene Yu, Eric Bartlett, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapyErin T Wong, Shao Hui Huang, Brian O'Sullivan, et al.European Urology Oncology|December 8, 2020
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell CancerJoão Lobo, Ricardo Leão, Ad J M Gillis, et al.Cancer|February 16, 2019
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicitiesYada Kanjanapan, Daphne Day, Lisa Wang, et al.Pageof 6